Oberland Capital
Overview
Oberland Capital provides innovative financing solutions to companies and royalty holders in the healthcare industry. We specialize in flexible investment structures customized to meet the specific capital requirements and strategic objectives of transaction partners globally. Our broad suite of financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, and investment in debt and equity securities. With a combination of deep industry knowledge and extensive structured finance experience, the Oberland Capital team has a history of creating value for our transaction partners. For more information please visit www.oberlandcapital.com.
Investment Focus
- Focus on pharmaceutical, biotechnology, medical device, and diagnostic industries
- Preference for companies in late-stage clinical development or under review by regulatory authorities
- Interest in monetization of royalty streams, acquisition of future product revenues, project-based financing structures, and investments in traditional debt and equity
Portfolio Companies
Reach Oberland Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Oberland Capital
What sectors does Oberland Capital invest in?
Oberland Capital invests in Healthcare Services, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Healthcare Equipment, and is based in New York, New York, United States. Oberland Capital is listed as a private investment firm in the ConnectSafely investor database.
What stage does Oberland Capital invest at?
Oberland Capital backs companies at Pre-Seed, Seed, Early Stage, Series A, Series B and Growth, writing cheques of 50M - 300M.
Which regions does Oberland Capital invest in?
Oberland Capital invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Who are the partners at Oberland Capital?
Team members listed for Oberland Capital include David Dubinsky (Chief Financial Officer) and Kristian Wiggert (General Counsel and Chief Compliance Officer).
What companies has Oberland Capital invested in?
Oberland Capital's portfolio includes Verastem Oncology, ClearPoint Neuro and Biohaven Pharmaceutical.
How do I contact Oberland Capital?
Oberland Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
